OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tixagevimab/Cilgavimab: Still a Valid Prophylaxis against COVID-19 New Variants?
Anna Gidari, Samuele Sabbatini, Sabrina Bastianelli, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 354-354
Open Access | Times Cited: 3
Anna Gidari, Samuele Sabbatini, Sabrina Bastianelli, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 354-354
Open Access | Times Cited: 3
Showing 3 citing articles:
From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2
Anoop Kumar, Prajna Tripathi, Prashant Kumar, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 459-459
Open Access | Times Cited: 2
Anoop Kumar, Prajna Tripathi, Prashant Kumar, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 459-459
Open Access | Times Cited: 2
Clinical characteristics and COVID-19-related outcomes of immunocompromised patients receiving tixagevimab/cilgavimab pre-exposure prophylaxis in Japan
Toshibumi Taniguchi, Tomoyuki Homma, Yoichi Tamai, et al.
Journal of Infection and Chemotherapy (2024) Vol. 31, Iss. 1, pp. 102467-102467
Closed Access
Toshibumi Taniguchi, Tomoyuki Homma, Yoichi Tamai, et al.
Journal of Infection and Chemotherapy (2024) Vol. 31, Iss. 1, pp. 102467-102467
Closed Access
Immunogenicity and safety of tixagevimab-cilgavimab for COVID-19 pre-exposure prophylaxis in immunocompromised 20 to <40 kg children and adolescents: A pilot, prospective, open-labeled study
Jassada Buaboonnam, Supattra Rungmaitree, Nuntawan Piyaphanee, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Closed Access
Jassada Buaboonnam, Supattra Rungmaitree, Nuntawan Piyaphanee, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Closed Access
